LENZ Therapeutics Inc. (LENZ)

AI Score

Unlock

20.18

1.64 (8.85%)

At close: Apr 11, 2025, 3:59 PM

20.40

1.09%

After-hours: Apr 11, 2025, 05:28 PM EDT

LENZ Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	20.16M	41.05M	84.15M	200.36M	185.86M	182.99M	128.51M	69.81M	47.73M	56.39M	75.17M	185.07M	376.98M	394.95M	382.11M	177.16M	19.82M
Short-Term Investments	188.87M	176.06M	112.08M	12.92M	n/a	51M	118.16M	194.28M	220.5M	235.29M	247.12M	154.11M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	114K	1.72M	1.72M	1.72M	17.04M	15.12M	7.7M	14.64M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.4M	1.4M	1.4M	21K	n/a	n/a	355K	889K	1.29M	844K	335K	711K	2.17M	12K	11K	728K	-1
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.89M	114K	n/a	n/a	n/a	20K	1.63M	n/a	2.2M	n/a	4.35M	4.57M	4.76M	6.28M	2.64M	3.1M	1.29M
Total Current Assets	211.92M	220.7M	199.35M	216.67M	188.02M	238.78M	251.17M	270.31M	275.37M	298.49M	326.64M	343.76M	381.74M	401.23M	384.75M	180.27M	21.1M
Property-Plant & Equipment	1.99M	1.91M	1.89M	627K	321K	25.73M	33.8M	37.08M	28.21M	20.39M	19.1M	19.5M	18.08M	14.91M	2.34M	1.92M	1.46M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.39M	3.3M	3.29M	648K	435K	27.45M	35.87M	39.69M	46.54M	36.35M	27.14M	34.85M	20.25M	14.92M	2.35M	2.65M	1.46M
Total Assets	215.3M	224.01M	202.64M	217.32M	188.46M	266.23M	287.04M	310M	321.9M	334.85M	353.79M	378.61M	401.99M	416.15M	387.11M	182.91M	22.56M
Account Payables	4.26M	2.76M	4.41M	7.13M	250K	3.71M	2.72M	1.99M	2.26M	3.97M	3.62M	3.07M	2.45M	1.76M	4.05M	1.61M	630K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	285K	n/a	2.91M	3.12M	n/a	4.56M	4.93M	5.64M	n/a	4.81M	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	2.73M	-2.87M	3.93M	5.76M	6.04M	1.65M	1.34M	4.06M	7M	3.04M	3.81M	4.5M	30.95M
Total Current Liabilities	10.41M	7.71M	8.58M	18.89M	4.8M	12.54M	12.27M	14.34M	13.04M	13.52M	12.07M	12.77M	12.14M	11.27M	7.86M	6.39M	32.05M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	64K	83K	111K	-1	49.45M	n/a	18.01M	12.42M	2.42M	n/a	-1	n/a	64K	64K	64K	316K
Total Long-Term Liabilities	814K	1.02M	1.13M	267K	77K	49.67M	50.63M	19.43M	12.57M	4.87M	3.26M	4.54M	n/a	4.75M	64K	64K	316K
Total Liabilities	11.22M	8.73M	9.72M	19.16M	4.87M	62.21M	62.9M	33.77M	25.61M	18.39M	15.33M	17.31M	12.14M	16.02M	7.92M	6.46M	32.36M
Total Debt	1.38M	1.58M	1.7M	589K	362K	53.11M	53.54M	4.54M	5.79M	7.01M	8.19M	10.18M	n/a	9.49M	n/a	n/a	n/a
Common Stock	1K	n/a	n/a	n/a	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	n/a	n/a
Retained Earnings	-145.01M	-132.36M	-122.15M	-111.89M	-367.05M	-344.14M	-321.65M	-266.34M	-242.4M	-217.8M	-193.12M	-167.19M	-141.35M	-122.42M	-107.83M	-90.3M	-70.59M
Comprehensive Income	196K	523K	-62K	-1K	n/a	-95K	-271K	-469K	-1.05M	-1.6M	-1.03M	-309K	-999	n/a	n/a	n/a	n/a
Shareholders Equity	204.08M	215.28M	192.92M	198.17M	183.58M	204.02M	224.15M	276.22M	296.29M	316.45M	338.46M	361.3M	389.84M	400.13M	379.18M	176.46M	-9.8M
Total Investments	188.87M	176.06M	112.08M	12.92M	114K	52.71M	119.88M	196M	237.54M	250.41M	254.82M	168.75M	n/a	n/a	n/a	n/a	n/a